Prof. Tobias F. Rinke de Wit

  • Senior Fellow, AIGHD.

  • Professor of Sustainable Health, Department of Global Health, Amsterdam UMC, University of Amsterdam.

  • Director Research, PharmAccess.

  • Director Research, Joep Lange Institute.

Professor Tobias F. Rinke de Wit (Ph.D.) is a molecular biologist and public health specialist. His research focus is primarily in the areas of (diagnosis of) infectious diseases in Africa, healthcare quality improvement, and innovative healthcare financing, supported by mobile health technologies. He is currently the Director of Research at PharmAccess and the Joep Lange Institute (JLI). Tobias stimulates multi-disciplinary implementation and evaluation research along with the agenda of PharmAccess. He serves as chair of the WHO Global HIV Drug Resistance Network advocacy workgroup. Another focus of his work is on COVID-19 in Africa, digital mobile rapid diagnostics, and the effect of African immune activation status on COVID-19 symptomatology.

Tobias holds an Academic Chair at the University of Amsterdam and leads, at the Department of Global Health and Amsterdam Institute for Global Health and Development (AIGHD), a team of scientists, Ph.D., and Master students. At AIGHD he coordinates a large-scale HIV test & treatment program in Tanzania. In his position as Principal Investigator at the Department of Global Health of the Amsterdam University Medical Centre Tobias develops the so-called ‘connected diagnostics’ technology for improved quality and financing of healthcare delivery in Africa. He published over 225 articles in peer-reviewed journals and is serving on the Boards of MondialDx and HealthInc Amsterdam.

View Prof Rinke de Wit’s publications (ResearchGate)

Next
Next

Dr. Dawit Wolday